Inclusion Criteria:  Willing and able to provide written informed consent Patients 18-80 years of age Patients with documented myocardial infarction > 90 days before study inclusion Clinically stable at the time of screening and able to tolerate the study procedure Female patients must not be pregnant at the time of FDG PET/CT imaging Patients included in other clinical trials could be included, provided this complies with specific local and research center requirements If after 6 months of patient recruitment it is foreseeable that the target number of patients will not be reached, patients who undergo FDG PET/CT imaging for cancer screening or surveillance can be included, provided that they have no evidence of an active malignancy on the scan or other exclusion criteria as listed below at study entry, including recent radio- and / or chemotherapy (≥ 12 months before the FDG PET/CT)  Exclusion Criteria:  Severe congestive heart failure (class III or IV according to NYHA, or pulmonary edema) Extra-cardiac illness that is expected to limit survival to less than 4-5 years; e. g. oxygen-dependent chronic obstructive pulmonary disease, active hepatitis or severe hepatic dysfunction, severe renal disease, active cancer Patients with chronic use of anti-inflammatory medication (except NSAIDs and inhaled corticosteroids) Patients with Diabetes Type I Insulin-dependent or uncontrolled Diabetes Type II (as HbA1C>7.5) Withdrawal of Informed consent